» Articles » PMID: 29134385

Robotic-assisted Multivisceral Resection for Rectal Cancer: Short-term Outcomes at a Single Center

Overview
Date 2017 Nov 15
PMID 29134385
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The safety and feasibility of robotic-assisted multivisceral resection for locally advanced rectal cancer remain unclear. The aim of this study was to assess the short-term outcomes of this procedure at our institution.

Methods: From December 2011 to December 2016, patients who underwent robotic-assisted multivisceral resection for rectal cancer were investigated. Patient demographics, treatment characteristics, perioperative outcomes, and pathological results were evaluated retrospectively.

Results: There were 31 patients; 17 men (54.8%) and 14 women (45.2%), with a median age of 65 years (range 40-82 years). Twenty-one patients (67.7%) had a cT4 tumor, 9 patients (29.0%) had a pT4b tumor, and all patients except one (96.8%) underwent complete resection of the primary tumor with negative resection margins. Eleven patients (35.5%) received neoadjuvant chemoradiation. The most commonly resected organ was the vaginal wall (n = 12, 38.7%), followed by the prostate (n = 10, 32.3%). Lateral lymph node dissection was performed in 20 patients (64.5%). The median operative time was 394 min (range 189-549 min), and the median blood loss was 41 mL (range 0-502 mL). None of the patients received intraoperative blood transfusions or required conversion to open. Overall, postoperative complications occurred in 11 patients (35.5%). The most frequent complication was urinary retention (n = 5, 16.1%), and none of the patients developed serious complications classified as Clavien-Dindo grades III-V.

Conclusions: Robotic-assisted multivisceral resection for rectal cancer is safe and technically feasible.

Citing Articles

Advantages of Robotic Total Mesorectal Excision With Partial Prostatectomy Compared With Open Surgery for Rectal Cancer: A Single-Center Retrospective Cohort Study.

Shimano R, Kasai S, Kagawa H, Shiomi A, Manabe S, Yamaoka Y Asian J Endosc Surg. 2025; 18(1):e70003.

PMID: 39778886 PMC: 11710923. DOI: 10.1111/ases.70003.


Beyond total mesorectal excision: The emerging role of minimally invasive surgery for locally advanced rectal cancer.

Perini D, Cammelli F, Scheiterle M, Martellucci J, DI Bella A, Bergamini C World J Gastrointest Surg. 2024; 16(8):2382-2385.

PMID: 39220075 PMC: 11362916. DOI: 10.4240/wjgs.v16.i8.2382.


The KRAS G12D mutation increases the risk of unresectable recurrence of resectable colorectal liver-only metastasis.

Chen K, Okamura Y, Hatakeyama K, Shiomi A, Kagawa H, Hino H Surg Today. 2024; 55(2):273-282.

PMID: 39083120 DOI: 10.1007/s00595-024-02900-3.


Low Hartmann's procedure versus abdominoperineal resection for rectal cancer, a propensity score matching cohort study.

Zhang X, Liu S, Liu L, Zhu Z BMC Gastroenterol. 2024; 24(1):194.

PMID: 38840108 PMC: 11155091. DOI: 10.1186/s12876-024-03244-5.


Robotic beyond total mesorectal excision for locally advanced rectal cancers: Perioperative and oncological outcomes from a multicentre case series.

Khan J, Piozzi G, Rouanet P, Saklani A, Ozben V, Neary P Eur J Surg Oncol. 2024; 50(6):108308.

PMID: 38583214 PMC: 11702198. DOI: 10.1016/j.ejso.2024.108308.


References
1.
Bretagnol F, Dedieu A, Zappa M, Guedj N, Ferron M, Panis Y . T4 colorectal cancer: is laparoscopic resection contraindicated?. Colorectal Dis. 2010; 13(2):138-43. DOI: 10.1111/j.1463-1318.2010.02380.x. View

2.
Fleshman J, Sargent D, Green E, Anvari M, Stryker S, Beart Jr R . Laparoscopic colectomy for cancer is not inferior to open surgery based on 5-year data from the COST Study Group trial. Ann Surg. 2007; 246(4):655-62. DOI: 10.1097/SLA.0b013e318155a762. View

3.
DeAngelis N, Landi F, Vitali G, Memeo R, Martinez-Perez A, Solis A . Multicentre propensity score-matched analysis of laparoscopic versus open surgery for T4 rectal cancer. Surg Endosc. 2016; 31(8):3106-3121. DOI: 10.1007/s00464-016-5332-9. View

4.
Buunen M, Veldkamp R, Hop W, Kuhry E, Jeekel J, Haglind E . Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial. Lancet Oncol. 2008; 10(1):44-52. DOI: 10.1016/S1470-2045(08)70310-3. View

5.
Zerey M, Hawver L, Awad Z, Stefanidis D, Richardson W, Fanelli R . SAGES evidence-based guidelines for the laparoscopic resection of curable colon and rectal cancer. Surg Endosc. 2012; 27(1):1-10. DOI: 10.1007/s00464-012-2592-x. View